Firma Tentamus Group, Autor bei Presse-Blog

As COFEPRIS Advances Nitrosamine Strategy, Lambda Científica Shares Critical Testing Insights

14. August 202515. August 2025 Firma Tentamus GroupBiotechnikanalytical methods, COFEPRIS, confirmatory testing, ISPE forum, laboratory expertise, Lambda Científica, method validation, mexico, mitigation, nitrosamine, pharmaceutical, product integrity, Regulatory Compliance, risk Management, tentamus

As COFEPRIS advances to Stage 2 (confirmation) and Stage 3 (mitigation) of its national nitrosamine risk management strategy, pharmaceutical companies in Mexico face increasing pressure to validate their analytical methods and implement robust mitigation plans. With these changes creating immediate Mehr

The Tentamus Group welcomes James Murphy as Vice President of Sales & Marketing for Tentamus North America

13. August 202513. August 2025 Firma Tentamus GroupFirmeninternanalytical testing, Business Development, client engagement, cross-functional collaboration, Customer Focus, data-driven decision-making, life sciences, Market expansion, marketing leadership, Operational Excellence, revenue growth, Sales strategy, service excellence, Strategic partnerships, team development

James Murphy is a seasoned commercial executive with over 18 years of experience driving strategic growth and leading high-performing sales and marketing teams in the life sciences and analytical testing sectors. Prior to joining Tentamus North America, James held a Mehr

BluTest Laboratories Expands UKAS Accreditation with EN 16777 for Advanced Virucidal Surface Testing

17. Juli 202517. Juli 2025 Firma Tentamus GroupBiotechnikBiocidal Products Regulation, BluTest Laboratories, clinical settings, disinfectant testing, EN 14476, EN 16777, healthcare environments, non-porous surfaces, product-compliance, regulatory approval, regulatory testing, surface disinfectants, tentamus, UKAS accreditation, virucidal efficacy

BluTest Laboratories – A Tentamus Company is pleased to announce a significant expansion to its UKAS accreditation scope with the addition of EN 16777, a critical virucidal Phase 2 Step 2 surface efficacy test designed for non-porous surfaces in medical Mehr

TentaConsult celebrates its fifth anniversary – A strong team, clear advice, reliable solutions!

14. Juli 202514. Juli 2025 Firma Tentamus GroupAllgemeinbiocompatibility, clinical evaluation, combination products, life sciences, manufacturing authorization, medical devices, münster, pharmaceuticals, product lifecycle, Quality Management, regulatory consulting, strategic consulting, tentaconsult, Tentamus Group, vigilance

Five years after its foundation, TentaConsult Pharma und Med GmbH can look back on an extremely positive year: the Münster-based company has established itself as a specialised consulting service provider for regulatory issues in the life sciences industry. With growing Mehr

TentaConsult feiert fünfjähriges Bestehen – Ein starkes Team, klare Beratung, verlässliche Lösungen!

14. Juli 202514. Juli 2025 Firma Tentamus GroupAllgemeinarzneimittel, Biokompatibilität, herstellerlaubnis, klinische Bewertung, Kombinationsprodukte, life sciences, medizinprodukte, münster, Produktlebenszyklus, qualitätsmanagement, regulatorische Beratung, strategische beratung, tentaconsult, Tentamus Group, vigilanz

Fünf Jahre nach der Gründung zieht die TentaConsult Pharma und Med GmbH eine überaus positive Bilanz: Das Unternehmen mit Sitz in Münster hat sich als spezialisierter Beratungsdienstleister für regulatorische Fragestellungen in der Life Sciences Branche etabliert. Mit wachsender Expertise und Mehr

Nova Biologicals Enhances Food Safety Portfolio with Major Expansion of Microbiological Testing Capabilities

7. Juli 20257. Juli 2025 Firma Tentamus GroupAllgemeinBacillus cereus, Clostridium perfringens, confirmatory testing, E. coli O157:H7, food safety, laboratory expansion, listeria, microbiological testing, pathogen detection, Public Health, salmonella, stec, supply chain

Nova Biologicals, a Tentamus Group laboratory, today announced a significant expansion of its food safety testing services. The expansion adds critical testing for several key pathogens, providing food industry clients with more comprehensive, reliable results and faster confirmation times to Mehr

Tentamus UK Announces Change in Country Management

23. Juni 2025 Firma Tentamus GroupFirmenintern.uk, biotechnology, change, country, Dr. Frederick J. Stubbins, expertise, growth, innovation, italy, laboratories, management, Nicola Berruti, services, tentamus, testing

The Tentamus Group announces a change in its country leadership. Effective July 1st, 2025, Nicola Berruti, Country Manager Tentamus Italy has been appointed as Country Manager for Tentamus Italy & UK. Nicola Berruti succeeds Dr. Frederick J. Stubbins, who will Mehr

CONIDIA CONIPHY launched a new service to track fungicide resistance

13. Juni 202513. Juni 2025 Firma Tentamus GroupDienstleistungenagriculture, Crop Protection, Disease Management, dna-sequencing, downy mildew, environment, Fungi RESIST, fungicide resistance, fungicides, Grapevine, nanopore sequencing, resistance monitoring, sample analysis, surveillance system, sustainability

CONIDIA CONIPHY has added a new service to its portfolio to detect and monitor fungicide resistance of downy mildew disease in grapevine. After 5 years of research, development efforts and investment in new DNA/gene sequencing technologies, CONIDIA CONIPHY launched a Mehr

Tentamus North America Spotlights Expert Legionella Testing Services to Address Critical Public Health Risks

9. Juni 202510. Juni 2025 Firma Tentamus GroupBiotechnikbiologicals, contamination, education, facilities, health, legionella, management, outreach, pneumonia, public, safety, services, testing, testing methodologies, water

As the risk of Legionnaires‘ disease remains a critical public health concern, Tentamus North America is reinforcing its commitment to facility safety by highlighting its expert Legionella testing services for industries across the continent. The company is providing advanced, reliable testing solutions Mehr

Accelerating clinical development in Vienna

30. Mai 2025 Firma Tentamus GroupBiotechnikbiotech companies, breakthrough science, clinical development, Clinical Trial Supply, Clinical Trials, effective therapies, expertise, GMP compliance, immunogenicity assays, infrastructure, pharmacodynamic services, pharmacokinetic services, regulatory guidance, trial logistics, vienna

Turning breakthrough science into effective therapies requires more than innovation — it demands the right expertise, infrastructure, and seamless execution. This complexity is addressed by ClinXTrials – a powerhouse alliance based in Vienna. Gouya Insights, VelaLabs – a Tentamus company Mehr

Autor: Firma Tentamus Group